Myelodysplastic syndromes (MDS) affect the production of blood cells in your bone marrow. Survival rate and outlook with MDS depend on several risk factors. MDS is sometimes referred to as ...

Myelodysplastic syndromes (MDS) are a group of blood cancers that affect the bone marrow and can result in a low levels of blood cells. When MDS affects red blood cells, it can lead to anemia in some ...

Myelodysplastic syndromes (MDS) are a group of disorders that affect bone marrow – the spongy tissue inside your bones where new blood cells are made. Bone marrow contains stem cells, or parent cells ...

Adding venetoclax to oral decitabine-cedazuridine improves responses in higher-risk MDS and CMML patients. Inqovi, an oral decitabine-cedazuridine combination, was FDA approved in 2020 for primary or ...

The report offers new insights into the limits of the BCL2 inhibitor among patients who have myelodysplastic syndromes. A new report explains why patients with myelodysplastic syndromes (MDS) become ...

There are more treatments today than ever before to help people with ongoing conditions manage their physical symptoms. But even with these medical advances, a diagnosis of myelodysplastic syndromes ...

PLEASANTON, Calif.--(BUSINESS WIRE)--Astex Pharmaceuticals, Inc., a wholly owned subsidiary of Otsuka Pharmaceutical Co. Ltd., based in Japan, today announced that the U.S. FDA has accepted for ...

Doctors of osteopathic medicine (DO) and doctors of medicine (MD) are two types of accredited doctor that can practice medical care in the United States. Both DOs and MDs require rigorous study in the ...